Other

Kremers-urban Company

Green Torch Solutions, LLC

Synertex

501 North American Biotechnology, Inc.

Steinbach, Pylant, and Hermann, L.l.c.

Steinbach, Pylant and Herman, L.l.c.

William J Hermann, Jr

Thomas Steinbach

Sudhakar S Wagle

Carl H Lawyer

Ali A Gawish

Bass Blundell

Phillip R Pylant

Henry A Mlcak

John R Zanek

S Ken Tanaka

Tod S Johnson

A drive system using multi-fuel engines to provide mechanical energy as an electric generator. The electric generator provides electrical energy to an electric motor which in turn provides mechanical energy to drive a load. The electric generator also provides electric energy to storage batteries. Electrical energy may be provided from the storage batteries to the electric motor as needed.

Motorized dual engine power system

A tradable investment unit is an inseparable combination of a predetermined quantity of a tradable security together with a put option contract for the predetermined quantity of the tradable security. The combination will specify the minimum price and thereby the maximum potential loss of the tradable investment unit to purchasers. The profit potential will be unlimited as the price of the tradable security increases above the cost of the tradable investment unit.

Tradable investment unit

A vehicle drive system uses multi-fuel engines to provide mechanical energy as an electric generator. The electric generator provides electrical energy to an electric motor which in turn provides mechanical energy to the drive train of a vehicle. The electric generator also provides electric energy to storage batteries. Electrical energy may be provided from the storage batteries to the electric motor as needed.

Vehicle drive system

A method for treating human immuno-deficiency virus infection (HIV-1), comprising administering a therapeutically effective amount of a mammalian liver extract characterized by being heat stable, insoluble in acetone, and soluble in water. A transdermal colloidal dispersion delivery system for use in the treatment of HIV-1 infection further comprises an emulsion of resolubilized, concentrated mammalian liver extract.

Method of treating HIV infection with transdermal gel containing mammalian liver extract

A method for treating human immuno-deficiency virus infection (HIV-1), comprising administering a therapeutically effective amount of a mammalian liver extract characterized by being heat stable, insoluble in acetone, and soluble in water. A rectal suppository colloidal dispersion delivery system for use in the treatment of HIV-1 infection further comprises an emulsion of resolubilized, concentrated mammalian liver extract.

Method of treating HIV infection with suppository containing mammalian

A therapeutic method for treating Epstein-Barr virus infection. The method comprises administering a therapeutically-effective amount of a mammalian liver extract, the extract being characterized by being heat stable, insoluble in acetone and soluble in water, peptide or peptide fragment selected from the groups consisting of Sequence Identification Numbers 1-9.

Method of treating an epstein-barr viral infection

A therapeutic method for treating hepatitis B infection. The method comprises administering a therapeutically-effective amount of a mammalian liver extract, the extract being characterized by being heat stable, insoluble in acetone and soluble in water, peptide or peptide fragment selected from the groups consisting of Sequence Identification Numbers 1-9.

Method of treating hepatitis B infection

A therapeutic method for treating Alzheimer's or related disease. The method comprises administering a therapeutically-effective amount of a mammalian liver extract, the extract being characterized by being heat stable, insoluble in acetone and soluble in water, peptide or peptide fragment selected from the groups consisting of Sequence Identification Numbers 1-9.

Method of treating the symptoms of Alzheimer's disease

A therapeutic method for treating viral infections and chronic fatigue syndrome. The method comprises administering a therapeutically-effective amount of a mammalian liver extract, the extract being characterized by being heat stable, insoluble in acetone and soluble in water.

Method of treating chronic fatigue syndrome

A container having a longitudinal passage is provided with a filter for collecting thereon cellular components having a particle size range of 5 microns or greater. Where the cellular components are to be harvested from a hostile environment such as voided urine specimen, the hostile environment is discharged, after passing through the filter, from the container through one end thereof to separate the cells from the hostile environment as soon as possible. The cellular components harvested on the filter are washed with a suitable media such as a saline solution and a nutrient preservative media, or fixative, such as by way of example formaldehyde is added to the container to assist in stabilizing the harvested cellular components on the filter. Where the cellular components are harvested from a hostile environment, a suitable closure may be added to one end of the container to close off the longitudinal passage before the preserving media is added. A closure is provided to seal off the collected cellular components in the container before transport.

Collection device and method of use thereof for the concentration,

The present invention relates to improvements in conventional protection barrel and cap packagings for hypodermic needles, whereby a structural guard is provided to encourage a user's fingers to locate directly behind the guard, and around the outer surface of an opening into the protected barrel. A person inserting a needle into a barrel automatically seeks to grasp the barrel proximate its open end, to avoid yawing of the barrel during the manipulative process. The present invention facilitates holding of a barrel proximate the opening, while providing, as an extension therefrom, a needle entrance guide means which extends axially and laterally therefrom. The laterally expanded barrel opening defines a transition ramp surface into the barrel open end. Accordingly, the present invention ensures that the needle will be guided into the barrel open end and towards the barrel closed end, even if the needle insertion step included an initial lateral misalignment, off the axial centerline of the barrel cap which extends the guard protections of the barrel needle barrel protector, through a cap which comprises an extending boss from the exterior surface of the cap, so that both needles will be guided away from accidental, manipulative stabbing. A fourth object of the present invention is to provide a protective barrel and extended cap packaging for enclosing a hypodermic needle and syringe assembly, wherein a disposable axially extending housing can be discarded, leaving a protective needle barrel to offer protection to the user, when reinserting only the barrel onto the needle.

Hypodermic needle protective barrel and cap packaging

A secure specimen collection vessel is provided, which in a preferred embodiment comprises a four-chamber base cup, 1, a twist-lock antirotation cap, 2, and a resilient sealing plug, 3. Clip-off drain tabs, 6, and vent tabs, 7, are located at the bottom end of the base cup, allowing each chamber to be drained individually for repeat analysis of a urine sample. The locking, antirotation cap, 2, prevents the contents of the vessel from being accidentally contaminated by the external environment, and also assures that any attempt to forceably remove the cap, 2, will result in visibly obvious damage to the collection vessel.

Toxicology specimen collection system

A disposable laboratory device for transfer of fluids, such as biological fluids or reagents, to specific wells of a centrifugal analyzer head. The device itself is a disposable, multi-compartmental system within an arcuately extending enclosure. In the preferred embodiment, the enclosure extends in a circular arc of approximately 120.degree., whereby one-third of the wells arranged around a circular centrifugal analyzer head can be filled with a single manipulation. Each of the compartments is preferably trapezoidal in plan view, with a bottom surface that includes an outlet means for each compartment proximate radially innermost portions of the enclosure. Equal volumes of pressurized gas distributed to each of the compartments exactly dispense equal volumes from each of the compartments into wells in a circular analyzer head which is held in a registration position. In combination with the disposable transfer device itself the present invention includes a rack specifically constructed to facilitate registration of the analyzer head with respect to the disposable enclosure, and pivoting of the enclosure into its horizontal operating orientation.

Disposable laboratory device for transfer of fluids to a centrifugal

A manipulative laboratory device for transferring biological fluid from one or more primary containers to an associated secondary set of containers through a disposable closed compartment system. The compartment system allows for greatly simplified decanting procedures, for example, in pouring off serum samples in blood analyses. The transfer device is preferably of transparent plastic material, and allows for complete isolation among respective samples and selective transfer of controlled volumes of biological fluid when combined with a pump, through means to apply equal volumes of pressurized gas to each of the compartments. The transfer device allows, serum, for example, to be held and filtered during transfer, while maintaining the serum within a closed compartment to reduce the risk of hepatitis and similar infectious transmissions to operating personnel. In combinations with the disposable transfer device, a pressurization device and rack constructions are provided to facilitate gang handling of a plurality of biological fluid specimens, in one operation.

Growing community of inventors

Sealy, TX, United States of America

William J Hermann, Jr